American House Dust Mite (Der f 15) IgE

If dust sets off sneezing, wheezing, or itchy skin, a standard dust mite blood test can show whether your immune system is sensitized to mites. This single-protein result asks a narrower question: whether you also make IgE against a less common American house dust mite protein.

That breadth matters because people whose mite antibodies cover more protein groups tend to have more asthma, more severe eczema, and more allergic disease overall. This is an exploratory component marker without validated Der f 15-specific cutoffs, so a single result works best as one detail in an allergy profile you're building, read against your symptoms and your other mite results.

What the Test Picks Up

IgE is the antibody class behind allergic reactions. When your immune system mistakes a harmless protein for a threat, antibody-making cells start producing IgE that fits that protein, and the IgE then arms the cells that release histamine the next time you're exposed.

The American house dust mite (Dermatophagoides farinae) makes more than a dozen numbered proteins that can trigger allergy. Group 15 belongs to the chitinase family of enzymes, which break down chitin in the hard outer covering of mites and insects. Your result reports how much IgE in your blood binds this single protein, in the usual allergy-antibody unit, kU/L.

Group 15 is a minor mite allergen. The major ones, recognized by more than half of mite-allergic people, are groups 1, 2, 23, and 35. Group 15 is recognized by a smaller share, roughly 20 to 40% in mite-allergic groups studied, and less often in some populations.

Most indoor mite allergy comes from two species. The American mite and the European mite (Dermatophagoides pteronyssinus) together account for more than 90% of mite allergy worldwide, and many of their proteins are close copies of each other, so IgE made against one often binds the other. The European version of this protein is called Der p 15, and it shares about 90% of its structure with Der f 15.

How Mite Allergy Spreads

Mite sensitization often starts with a small set of proteins, especially groups 1, 2, and 23, then widens over years. Some people later recognize higher-numbered groups such as 15. Researchers call this molecular spreading, and a positive Der f 15 result usually means it has happened to you. Some of the strongest long-term data measured Der p 15, the European counterpart, so that evidence is a close but not identical bridge.

Sources: Batard et al.; Posa et al.; Park et al.

What this means for you: a positive result here points to a broader, more developed mite-sensitization profile. If you already know you react to mites, it suggests the reaction has probably spread past the starting proteins, which is the pattern linked to more persistent and more severe disease in the sections below.

Asthma and Year-Round Nasal Allergies

The clearest evidence comes from children. Mite-allergic children with asthma reacted to more mite proteins, and at higher antibody levels, than mite-allergic children without asthma. In the group of about 720 children tracked through their first two decades, broader mite sensitization predicted mite-triggered nasal allergy at the time and asthma later on.

Allergic rhinitis is the medical name for the year-round sneezing, congestion, and runny nose that mites cause. In a Paris birth cohort of about 700 children, those with stronger mite sensitization had higher risks of both asthma and allergic rhinitis than children with weak or no sensitization.

Eosinophils are white blood cells that drive allergic inflammation. In asthmatic children sensitized to mites, higher mite IgE went along with more eosinophils in the blood and more nitric oxide in exhaled breath. Nitric oxide in breath rises when the airways are inflamed. Lung function measurements did not track the IgE level.

Most of these studies measured IgE to whole mite extract or to broad panels of mite proteins, often from the European mite. Group 15 was one of the later-spreading proteins in those panels, and a reaction to it is one sign of the wider spread those studies tied to asthma. If you have nasal symptoms at home and a positive result, the useful next step is finding out how many mite proteins you react to, since a broad profile is the one that leans toward asthma, especially in children.

Eczema

Eczema comes with some of the broadest mite profiles studied. Minor American-mite proteins, group 15 among them, were recognized more widely in people with eczema than in people with only nasal or chest allergy, where IgE tends to focus on groups 1 and 2. In a separate study of about 380 people with mite allergy, reacting to more than three mite proteins was associated with asthma and/or eczema, and several minor European-mite proteins were more common in people with eczema. That second study did not measure Der f 15, so the evidence supports the broader-profile idea rather than making this single marker a proven eczema marker.

Earlier work found moderate to severe eczema strongly associated with mite sensitization. Among infants under two, early mite sensitization went along with more eczema and more food allergy. Mites may also carry bacteria, and in people with eczema they appear to be one route to developing IgE against bacterial proteins.

What this means for you: if you have eczema that won't settle, a positive Der f 15 result fits a broad mite profile. It is a reason to treat mite exposure as one part of your skin plan, along with the usual creams and triggers.

Sensitization Versus Allergy

A positive result means your immune system has made IgE against this protein. Sensitization plus symptoms when you're exposed is allergy, and the two don't always line up, which is why a high number on its own doesn't tell you how bad your symptoms are or will be. Sensitization without symptoms is common.

Even the standard whole-mite blood test is an imperfect stand-in for real reactions. In a nasal challenge, an allergist sprays mite extract into your nose and watches what happens. Compared with that challenge, whole-mite blood tests catch many, but not all, clinically relevant mite allergies and can also be positive in people who don't react on challenge. Group 15 isn't one of the components used to diagnose mite allergy. Standard component testing is built around groups 1 and 2, plus groups such as 5, 7, 21, and 23, which together pick up 98 to 99% of mite-sensitized people. So a group 15 result gets read as part of a profile, not as a diagnosis on its own.

Sensitization also fades with age for many people. In a long-term study, IgE to individual mite proteins declined as people got older, along with fewer and milder asthma and rhinitis symptoms. So an incidental positive with no symptoms deserves less concern than the same result alongside a nightly cough.

When Results Can Be Misleading

The most common source of confusion is the testing platform, and the method behind this test can vary between labs.

• Different testing platforms: single-allergen tests and multi-allergen chips usually agree on whether you're positive, but their numbers can differ a lot, so compare results only from the same lab and method.
• Very high total IgE: people with a great deal of IgE overall can show weak, low-quality binding that reads as positive on individual proteins, so comparing this result with your total IgE helps.
• Anti-IgE injections: omalizumab and related treatment can change measured total and allergen-specific IgE, so pre-treatment and on-treatment results are not a clean trend.
• Look-alike mite proteins: IgE made against the European mite's version of this protein can bind the American one, so a positive doesn't prove which species started the reaction.

A negative blood result has a blind spot too. Some people make mite IgE only in the lining of the nose. This is called local allergic rhinitis, and blood tests stay negative in it. Certain lab factors can occasionally affect any single result.

How Trends Behave

Mite IgE changes slowly. In people getting no treatment, mite-specific IgE often stays fairly stable over months, so a repeat test after a few weeks usually won't show you anything useful. Over years, levels drift with age, exposure, and treatment, and that slower trajectory is what's worth following.

One pattern looks backwards. Mite IgE often rises during the first months of allergy shots, while the dose is being built up, and only later settles and slowly falls. The early bump is your immune system responding to a large, deliberate dose of mite protein, and at the same time it's making more blocking antibodies of a different class, called IgG4.

So a higher number early in treatment is expected and doesn't mean the shots are failing. Rising IgG4 alone also didn't predict who improved, which leaves your symptoms as the main measure of whether treatment is working.

What to Do With Your Result

Read Der f 15 alongside the rest of your mite results. These combinations cover most situations.

• Positive here and for groups 1 and 2, with symptoms at home: you have a broad mite sensitization profile. Immunotherapy is the treatment that changes the underlying immune response, and mite extracts helped people sensitized to minor proteins as well as major ones. It needs a prescription, so this is the point to see an allergist.
• Positive here but negative for groups 1 and 2: this runs against the usual order of spreading. Check your total IgE and whole-mite extract result, and repeat on the same platform before reading much into it.
• Negative here, with mite symptoms: this is expected for most mite-allergic people, since group 15 is a minor protein. Groups 1, 2, and 23 carry more weight, and if every blood test is negative, nasal testing for local allergy is the next step.
• Positive with both asthma and nasal allergies: in children, high mite IgE plus both conditions raised the risk of whole-body reactions to mite shots, which is worth raising with your allergist before starting.

A blood count with eosinophils and a total IgE level add context on how active your allergic inflammation is. If eczema is your main problem, a dermatologist who works with allergists can fold mite exposure into your treatment.